BAK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Braskem SA (BAK) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The company is facing severe financial challenges, including declining revenue, negative earnings, and liquidity concerns. Analysts have downgraded the stock with reduced price targets, and technical indicators show a bearish trend. There are no positive catalysts or trading signals to suggest an immediate recovery or upside potential.
The MACD histogram is negative and expanding, indicating bearish momentum. The RSI is neutral at 35.245, but close to oversold territory. Moving averages are converging, showing no clear trend. The stock is trading near its support level of 3.886, with resistance at 4.707. Overall, the technical indicators suggest a bearish trend.
NULL identified.
Analysts downgraded the stock to 'Underperform' and 'Sell,' citing liquidity concerns and challenges in the petrochemical market.
The company faces $383M in debt maturity this year, further straining its financial flexibility.
Financial performance is deteriorating, with significant YoY declines in revenue, net income, EPS, and gross margin.
Projected EPS for the upcoming quarter is -$0.98, a 151.28% decrease YoY.
In Q3 2025, revenue dropped by 17.18% YoY to $3.18B. Net income fell by 95.54% YoY to -$4.77M. EPS declined by 92.31% YoY to -$0.01. Gross margin dropped by 76.18% YoY to 2.52%. The company is experiencing significant financial deterioration.
BofA downgraded Braskem to 'Underperform' with a price target of $2.80, citing liquidity concerns and cash burn. Citi downgraded the stock to 'Sell,' citing valuation concerns and challenges in the petrochemical market. Both ratings indicate a bearish outlook.
